Etokimab (ANB-020) is a humanised monoclonal antibody targeting IL-33, capable of inhibiting IL-33-induced neutrophil migration, and is being studied for atopic dermatitis, asthma, and sinusitis.
Purity:
97.20%
CAS Number:
[2022981-44-6]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
